NewcelX Ltd. (NCEL)

US · Healthcare · Biotechnology

$2.50-12.28%

Last close · 2026-10-16

Key statistics

Market cap

$16.8M

P/E

5.3

Forward P/E

0.0

P/B

2.74

Book value

$1.12

EPS (TTM)

$0.55

52-week high

$18.10

52-week low

$1.83

50-day MA

$3.22

200-day MA

$3.07

Beta

0.57

Analysts rate NewcelX Ltd. a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $23.00.

Insiders

65.58%

Institutions

0.23%

Fund	Stake
HRT FINANCIAL LLC	0.19%
JONES FINANCIAL COMPANIES LLLP	0.01%
Caitong International Asset Management Co., Limited.	0.00%
CoreCap Advisors, LLC	0.00%
Tower Research Capital LLC	0.00%
UBS Group AG	0.00%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for NewcelX Ltd. — free to start.

Data updated 2026-10-18.